A Study of VV-14305 for the Treatment of Thyroid Eye Disease

Clinical trial NCT07404111 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07404111
Sponsor: Kriya Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thyroid Eye Disease (TED)

Start date: 2026-02-01
Primary completion: 2028-02-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.